Is Green Tea Mood Randomized Trial safe?

Updated August 2026

Quick Answer

Green Tea Mood Randomized Trial has evidence relevant to safety, limits, and clinician-discussion contexts, but conclusions should stay close to the cited sources. One representative finding is: 7 8 9 10 11 12 13 Pathophysiology has revealed that one of the primary risk factors for depression is chronic stress due to glucocorticoid effects on the hypothalamic–pituitary–adrenal (HPA) axis [].

Key Takeaways

  • 017 8 9 10 11 12 13 Pathophysiology has revealed that one of the primary risk factors for depression is chronic stress due to glucocorticoid effects on the hypothalamic–pituitary–adrenal (HPA) axis []. [Cavanah Aidan M. (2026)]
  • 02BDNF exerts neuroprotective and neuroactivating properties on both excitatory and inhibitory neurons, with high concentrations found in the hippocampus and frontal cortex []. [Cavanah Aidan M. (2026)]
  • 03These studies support the ‘neurotrophin hypothesis of depression’, which states that reduced levels of BDNF in the brain contribute to cell atrophy in the hippocampus and prefrontal cortex []. [Cavanah Aidan M. (2026)]
  • 041 2 3 4 5 6 Mood disorders are notable disruptions in emotions that occur internally but can impact a person’s behavior externally []. [Cavanah Aidan M. (2026)]
The current Migaku evidence database contains 2 reusable source documents for Green Tea Mood Randomized Trial. This answer focuses on safety, limits, and clinician-discussion contexts. - 7 8 9 10 11 12 13 Pathophysiology has revealed that one of the primary risk factors for depression is chronic stress due to glucocorticoid effects on the hypothalamic–pituitary–adrenal (HPA) axis []. [Cavanah Aidan M. (2026); evidence level 2] - BDNF exerts neuroprotective and neuroactivating properties on both excitatory and inhibitory neurons, with high concentrations found in the hippocampus and frontal cortex []. [Cavanah Aidan M. (2026); evidence level 2] - These studies support the ‘neurotrophin hypothesis of depression’, which states that reduced levels of BDNF in the brain contribute to cell atrophy in the hippocampus and prefrontal cortex []. [Cavanah Aidan M. (2026); evidence level 2] - 1 2 3 4 5 6 Mood disorders are notable disruptions in emotions that occur internally but can impact a person’s behavior externally []. [Cavanah Aidan M. (2026); evidence level 2] - Polyphenols strengthen the intestinal barrier and reduce endotoxemia; cocoa bean shell extracts protected against oxysterol‐induced intestinal damage and improved gut microbiota composition in preclinical models (Alia et al. ). [Akif Adnan (2026); evidence level 3] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.

Sources

  1. A Randomized Controlled Trial to Determine the Effects of Curcumin and Epigallocatechin-3-Gallate Supplementation on Serum Brain-Derived Neurotrophic Factor and Mood Disturbance in Adults
  2. Dietary Polyphenols in Non‐Communicable Chronic Diseases: Neuro–Enteric Mechanisms, Multi‐Omics Biomarkers and Translational Opportunities